MedPath

Feasibility of Mutational Analysis of Non-Small Cell Lung Cancer (NSCLC) Using Low-volume Lung Aspirates

Withdrawn
Conditions
Lung Cancer
Registration Number
NCT01482572
Lead Sponsor
Samsung Medical Center
Brief Summary

The purpose of this study is to evaluate the feasibility of aspiration samples for mutational analysis in patients with a non-small cell lung cancer (NSCLC).

Detailed Description

The investigators will compare results of mutational analysis from a core needle biopsy and fine needle aspiration.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • primary tumor or a metastatic lung lesion requested for mutational analysis
Exclusion Criteria
  • a) lesions located adjacent to the large central bronchi or vessels
  • b) peribronchovascular lesions with prominent internal CT air-bronchograms, which were considered difficult to be avoided by needle pass
  • c) lesions in patient with severe respiratory compromise

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success rates for mutation analysisone year
Secondary Outcome Measures
NameTimeMethod
Technical success rate of biopsy procedureone year

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Samsung Medical Center
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.